Efficacy and Safety of HCP1102 Capsule

Inclusion: * Age≥15 * Mild or moderate asthma patients with allergic rhinitis * Patient who meet all criteria of rhinitis * Patients understood the contents and purpose of this trial and signed informed consent form * Patients who are capable and willing to write subject diary * Patients who agree with maintain same environment during clinical trials Exclusion: * Nonallergic rhinitis * Severe asthma * Other pulmonary disease (pulmonary tuberculosis, COPD) except Asthma * Medical history of hypertrophic cardiomyopathy, cancer, renal disease, Liver disease, cardiovascular disease, respiratory disease, endocrine disorder, CNS disorder that effect safety * Medical history of gastrointestinal surgery or gastrointestinal disorders that effect drug absorption * Alcohol abuse or Drug abuse * Genetic factor of galactose intolerance or Lapp lactase deficiency or glucose-galactose malabsorption * pregnant or breast-feeding women or men/women of childbearing age that they don't use contraceptives * Patient who administered other investigational products within 30 days * Current smoker Judged to be inappropriate for the study by the investigator after reviewing other reasons